University of Nottingham: Interrupting the treatment of vuln

A major clinical trial, led by experts at the University of Nottingham working in partnership with several Universities and NHS hospitals, has found that by interrupting the treatment of vulnerable people on long-term immune supressing medicines for

Related Keywords

United Kingdom , Manchester , Brompton , Medway , Nottingham , London , City Of , Jonathan Cook , John Iredale , Rosemary Boyton , Andy Ustianowski , University Of Oxford , University Of Nottingham , University Of Manchester , Department Of Infectious Disease , Honorary Consultant Rheumatologist At Nottingham University Hospitals , National Institute For Health , Imperial College London , National Infection Specialty , Oxford Clinical Trials Research Unit , Care Research , Vaccine Research Programme , Lung Division , Research Council , Queen Mary University London , Vaccine Response On Off Methotrexate , National Institute , Medical Research , Queen Mary University , Lancet Respiratory , Professor Abhishek , Honorary Consultant Rheumatologist , Nottingham University Hospitals , Research Programme , Joint National Infection Specialty Lead , Professor Rosemary Boyton , Respiratory Medicine , Infectious Disease , Royal Brompton Hospital , Associate Professor Jonathan Cook , Executive Chair , Medical Research Council ,